Dmytrenko, I. V., Minchenko, Z. M., Fedorenko, V. V., & Dyagil, I. S. (2019). SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES FOR THE OUTCOMES AFTER THE SECOND LINE NILOTINIB THERAPY IN THE CHRONIC MYELOID LEUKEMIA PATIENTS. International Journal of Medicine and Medical Research, 5(1), 33-39. https://doi.org/10.11603/ijmmr.2413-6077.2019.1.10305